FibroGen Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company
Key Highlights
FibroGen Inc (FibroGen) is a biopharmaceutical company that discovers, and develops medicines for the treatment of anemia, cancer, and fibrotic disease. The company is investigating its lead pipeline candidate: roxadustat, an oral small molecule inhibitor of hypoxia-inducible factor (HIF) prolyl hydroxylases (HIF-PH), for the treatment of anemia related to chronic kidney disease (CKD) in dialysis-dependent (DD) patients; and in Phase II/III clinical trials for anemia associated with myelodysplastic syndromes. Its pipeline also comprises a biosynthetic corneal implant; and pamrevlumab, a human monoclonal antibody inhibitor of connective tissue growth factor (CTGF), in Phase III clinical studies for the treatment of idiopathic pulmonary fibrosis and pancreatic cancer; and in Phase II clinical studies for the treatment of duchenne muscular dystrophy. FibroGen is headquartered in San Francisco, California, the US.
Scope
- Detailed information on FibroGen Inc required for business and competitor intelligence needs
- A study of the major internal and external factors affecting FibroGen Inc in the form of a SWOT analysis
- An in-depth view of the business model of FibroGen Inc including a breakdown and examination of key business segments
- News about FibroGen Inc, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
- Gain understanding of FibroGen Inc and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess FibroGen Inc as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on FibroGen Incs business structure, strategy and prospects.
Note: Some sections may be missing if data is unavailable for the company.
Companies mentioned
Vifor Pharma Ltd
Sandoz Inc
Pfizer Inc
Kyowa Hakko Kirin Co Ltd
Johnson & Johnson
Japan Tobacco Inc
GlaxoSmithKline Plc
F. Hoffmann-La Roche Ltd
Celgene ...
Vifor Pharma Ltd
Sandoz Inc
Pfizer Inc
Kyowa Hakko Kirin Co Ltd
Johnson & Johnson
Japan Tobacco Inc
GlaxoSmithKline Plc
F. Hoffmann-La Roche Ltd
Celgene Corp
Boehringer Ingelheim International GmbH
Bayer AG
Amgen Inc
Akebia Therapeutics Inc
Acceleron Pharma Inc
3SBio Inc
Table of Contents
Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 - About the Company
FibroGen Inc - Key Facts
FibroGen Inc ...
Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 - About the Company
FibroGen Inc - Key Facts
FibroGen Inc - Key Employees
FibroGen Inc - Key Employee Biographies
FibroGen Inc - Major Products and Services
FibroGen Inc - History
FibroGen Inc - Company Statement
FibroGen Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
FibroGen Inc - Business Description
Business Segment: Development and Other Revenue
Overview
Performance
Business Segment: License Revenue
Overview
Performance
Business Segment: Product Revenue
Overview
Performance
Geographical Segment: All other
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Japan
Performance
R&D Overview
FibroGen Inc - Corporate Strategy
FibroGen Inc - SWOT Analysis
SWOT Analysis - Overview
FibroGen Inc - Strengths
FibroGen Inc - Weaknesses
FibroGen Inc - Opportunities
FibroGen Inc - Threats
FibroGen Inc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
FibroGen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
FibroGen Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
FibroGen Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Jun 05, 2019: FibroGen appoints Suzanne Blaug to Board of Directors
May 09, 2019: FibroGen reports first quarter 2019 financial results
Feb 27, 2019: Fibrogen reports fourth quarter and full year 2018 financial results
Dec 06, 2018: FibroGen names Maykin Ho, Ph.D., as board director
Nov 08, 2018: FibroGen reports third quarter 2018 financial results
Aug 07, 2018: FibroGen reports second quarter 2018 financial results
May 09, 2018: FibroGen Reports First Quarter 2018 Financial Results
Feb 27, 2018: FibroGen Announces Fourth Quarter and Full Year 2017 Financial Results
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
List of Tables
FibroGen Inc, Key Facts
FibroGen Inc, Key Employees
FibroGen Inc, Key Employee Biographies
FibroGen Inc, Major Products and Services
FibroGen Inc, History ...
List of Tables
FibroGen Inc, Key Facts
FibroGen Inc, Key Employees
FibroGen Inc, Key Employee Biographies
FibroGen Inc, Major Products and Services
FibroGen Inc, History
FibroGen Inc, Subsidiaries
FibroGen Inc, Key Competitors
FibroGen Inc, Ratios based on current share price
FibroGen Inc, Annual Ratios
FibroGen Inc, Annual Ratios (Cont...1)
FibroGen Inc, Interim Ratios
FibroGen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
FibroGen Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
FibroGen Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
List of Figures
FibroGen Inc, Performance Chart (2014 - 2018)
FibroGen Inc, Ratio Charts
FibroGen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD ...
List of Figures
FibroGen Inc, Performance Chart (2014 - 2018)
FibroGen Inc, Ratio Charts
FibroGen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
FibroGen Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019